Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma

Citation
Nv. Adsay et al., Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma, PANCREAS, 18(2), 1999, pp. 111-116
Citations number
28
Categorie Soggetti
da verificare
Journal title
PANCREAS
ISSN journal
08853177 → ACNP
Volume
18
Issue
2
Year of publication
1999
Pages
111 - 116
Database
ISI
SICI code
0885-3177(199903)18:2<111:UOFISH>2.0.ZU;2-9
Abstract
Often the diagnosis of pancreas cancer needs to be established from limited cytology specimens or small biopsies. Most ductal adenocarcinomas are hist ologically well to moderately differentiated and mimicked closely by pancre atitis, and therefore the microscopic diagnosis can be difficult. In additi on, there appears to be significant heterogeneity in the outcome of the pat ients with pancreatic cancer, which cannot be predicted accurately by curre nt prognosticators such as the grade and stage of the tumor. Therefore, the re is need for methods that can be used as adjuncts to routine diagnostic a nd prognostic parameters. This study was designed to test the utility of th e fluorescent in situ hybridization (FISK) method in identifying the molecu lar alterations, particularly the ones that have been detected with relativ ely high frequency in pancreas cancer. Formalin-fixed and paraffin-embedded tissues of 10 cases were enumerated for chromosome 7, 8, 17, 18, and 20 co py numbers by using alpha-satellite probes, and for c-myc by using a gene-s pecific probe. The number of signals per nucleus (reflecting chromosomal co py number and status of c-myc amplification) were counted in more than two areas containing 50-500 cells. Because of tumor heterogeneity, monosomy (lo ss of one chromosome copy) was defined arbitrarily as one signal in >25% of nuclei. C-myc amplification was defined as more than two gene copies in >2 0% of the cells. The most frequent signal losses were found in chromosomes 8 (four of 10 cases) and chromosome 17 (four of 10), followed by 20 (three of 10) and Is (two of 10). No loss of chromosome 7 was detected. In contras t, gains in chromosome copy number were identified in only one of 10 tumors , which showed gain of both chromosome 7 and 18. Amplification of c-mye gen e was detected in two of 10 cases, but neither of the two had aneuploidy fo r chromosome 8, where the c-myc gene is located. In addition, loss in c-mye signal was observed in one case that also showed loss of chromosome 8 copy number. FISH can be used to detect chromosomal changes in pancreatic cance r; abundance of lyric enzymes in this organ is not an impediment for the ap plicability of this technique. Therefore it can potentially be used in the future as an adjunct to the conventional diagnostic and prognostic markers. This study confirms that loss of chromosomes, particularly chromosomes 17 and 18, which carry the p53 and DCC genes, are common in pancreas cancer. C hromosome 20 is also frequently lost. In addition, in this study, alteratio ns of chromosome 8, which is seen commonly in prostatic adenocarcinoma but has not been previously documented in pancreatic cancer, also was detected in five of 10 tumors. Furthermore, amplification of the c-myc gene, which i s located in chromosome 8, was found in the two of the remaining five cases . Further studies are needed to confirm this high incidence of chromosome 8 and c-myc alterations and their possible role in the pathogenesis of pancr eatic adenocarcinoma.